Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05020197
Other study ID # 69HCL20_0814
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 23, 2022
Est. completion date December 23, 2024

Study information

Verified date October 2023
Source Hospices Civils de Lyon
Contact Ludivine NOHALES, MD
Phone 04 72 11 01 17
Email ludivine.nohales@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Attachment theory models the emotional bonding that is activated in situations of danger, via mental representations of self and others. Four types of attachment (TA) exist in adults: 3 insecure (Preoccupied, Detached, Fearful) and 1 secure. Attachment type is a major factor in the development of Post-Traumatic Stress Disorder (PTSD), a frequent and disabling mental disorder that occurs after a traumatic event. A meta-analysis based on Anglo-Saxon studies including various populations (general, military or clinical) (n=9268 patients) suggested an association between Fearful BP and high level of PTSD symptoms (r=0.44). Nevertheless, these results did not allow the identification of variations related to the individual risk factors (RDFs) of the subject and his environment, especially in the French socio-cultural context. The investigators propose to study the association between LDs and the risk of PTSD in the days following exposure, their mutual influence in the months following, and their associated factors. Thus, a prospective cohort study among French adult victims of a traumatic event could objectify the link between BP - as close as possible to the event - and the risk of PTSD.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date December 23, 2024
Est. primary completion date December 23, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Major patient - Having experienced a Potentially Traumatic Event within 3 days and according to DSM5 criterion A: Exposure to actual or potential death, serious injury, or sexual violence in one (or more) of the following ways: Directly experiencing the traumatic event, witnessing the event in person by others, learning that the traumatic event (violent or accidental) was experienced by a close family member or friend, experiencing repeated or extreme exposure to the harrowing details of the traumatic event (e.g., first responders or police officers) (exposure through electronic media, television, films, or photographs, if the exposure is work-related) - Good understanding of oral and written French - Having given written consent - Patient affiliated to a social security scheme Exclusion Criteria: - Psychiatric pathology with current clinical instability (agitation, maladaptive consciousness...) or patient unable to understand questionnaires - Vulnerable adult (curatorship, guardianship) - Non French resident

Study Design


Intervention

Diagnostic Test:
self-questionnaires on attachment and PTSD
The questionnaires (attachement type, PTSD symptoms) are administered face to face at the inclusion visit (at D0-D3). Validated self-questionnaires in French will be sent to the patients, either electronically or by post, according to their choice at D30 and D90. To describe the characteristics of the subjects, socio-demographic data, lifestyle, and medical history will be collected. The questionnaires will be administered three times to study the evolution of the parameters over time.

Locations

Country Name City State
France Service de médecine et santé au travail des HCL Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire Type of attachment Disorder will be measured at inclusion by the ECR-R attachment questionnaire. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree. Day 30
Primary Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Risk of developing Post Traumatic Stress Disorder. Items are rated on a 5 point scale. The maximum score is 80. Day 30
Primary Correlation between Questionnaire PCL-5 AND ECR-R attachment questionnaire Correlation of outcome 1 and outcome 2 Day 30
Secondary Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Risk of Post-Traumatic Stress Disorder at 90 days. Items are rated on a 5 point scale. The maximum score is 80. Day 90
Secondary Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Type of attachment. Items are rated on a 5 point scale. The maximum score is 80. Day 90
Secondary Correlation between PCL-5 questionnaire.And PCL-5 questionnaire.at D90 Correlation between the type of attachment and the risk of Post-Traumatic Stress Disorder Day 90
Secondary Relationship Scales Questionnaire (RSQ) 30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized) Day 3
Secondary Relationship Scales Questionnaire (RSQ) 30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized) Day 30
Secondary Relationship Scales Questionnaire (RSQ) Measure of Psychometric performance; 30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized) Day 90
Secondary Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree Day 3
Secondary Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree Day 30
Secondary Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree Day 90
Secondary Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) Risk of Post Traumatic Stress Disorder (D90). Items are rated on a 5 point scale. The maximum score is 80. Day 90
Secondary Impact of Event Scale Revised The IES-R consists of a list of 22 symptoms of PTSD. The person indicates the intensity with which each symptom has manifested itself over the past 7 days, by self-reporting their response on a 5-point Lykert-type scale, ranging from 0 ("Not at all") to 4 ( "Extremely"). The total IES-R score is calculated by adding the values obtained for the 22 items (scores 0-88). Day 3
Secondary Relationship Scales Questionnaire (RSQ) 30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized) Day 90
See also
  Status Clinical Trial Phase
Recruiting NCT04317820 - Deep Brain Reorienting in Post-traumatic Stress Disorder N/A
Completed NCT05112003 - Translingual Neurostimulation for the Virtual Treatment of Post-Traumatic Stress Disorder: A Feasibility Pilot N/A
Recruiting NCT04518267 - Anger and Psychotrauma: Data From Military and Civilians
Completed NCT02502604 - Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder N/A
Completed NCT02256566 - Cognitive Training for Mood and Anxiety Disorders N/A
Terminated NCT02234687 - A mGlu2/3 Agonist in the Treatment of PTSD Phase 1
Completed NCT02213900 - Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy Phase 4
Completed NCT01738308 - The Effects of Healing Touch on Post Operative Pediatric Patients N/A
Terminated NCT02520726 - PTSD Prevention Study Examining the Efficacy of Sertraline in Burn Victims Phase 4
Completed NCT01437891 - Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) N/A
Completed NCT01517711 - Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Phase 4
Completed NCT01199107 - Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01998100 - Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD) Phase 3
Completed NCT01231711 - Improving Quality-of-life and Depressive Symptoms of Combat Veterans Via Internet-based Intervention Phase 1
Completed NCT00680524 - Telephone-based Care for OEF/OIF Veterans With PTSD N/A
Completed NCT00348036 - Group Intervention for Interpersonal Trauma N/A
Completed NCT00838006 - Psychophysiologic Predictors of Post-deployment Mental Health Outcomes N/A
Completed NCT00525226 - Evaluating the Effects of Stress in Pregnancy N/A
Completed NCT00158262 - Effect of Propranolol on Preventing Posttraumatic Stress Disorder Phase 4
Completed NCT00183690 - Prolonged Exposure Therapy Versus Active Psychotherapy in Treating Post-Traumatic Stress Disorder in Adolescents Phase 1